Literature DB >> 19053285

Structural basis of substrate recognition by hematopoietic tyrosine phosphatase.

David A Critton1, Antoni Tortajada, Geoffrey Stetson, Wolfgang Peti, Rebecca Page.   

Abstract

Hematopoietic tyrosine phosphatase (HePTP) is one of three members of the kinase interaction motif (KIM) phosphatase family which also includes STEP and PCPTP1. The KIM-PTPs are characterized by a 15 residue sequence, the KIM, which confers specific high-affinity binding to their only known substrates, the MAP kinases Erk and p38, an interaction which is critical for their ability to regulate processes such as T cell differentiation (HePTP) and neuronal signaling (STEP). The KIM-PTPs are also characterized by a unique set of residues in their PTP substrate binding loops, where 4 of the 13 residues are differentially conserved among the KIM-PTPs as compared to more than 30 other class I PTPs. One of these residues, T106 in HePTP, is either an aspartate or asparagine in nearly every other PTP. Using multiple techniques, we investigate the role of these KIM-PTP specific residues in order to elucidate the molecular basis of substrate recognition by HePTP. First, we used NMR spectroscopy to show that Erk2-derived peptides interact specifically with HePTP at the active site. Next, to reveal the molecular details of this interaction, we solved the high-resolution three-dimensional structures of two distinct HePTP-Erk2 peptide complexes. Strikingly, we were only able to obtain crystals of these transient complexes using a KIM-PTP specific substrate-trapping mutant, in which the KIM-PTP specific residue T106 was mutated to an aspartic acid (T106D). The introduced aspartate side chain facilitates the coordination of the bound peptides, thereby stabilizing the active dephosphorylation complex. These structures establish the essential role of HePTP T106 in restricting HePTP specificity to only those substrates which are able to interact with KIM-PTPs via the KIM (e.g., Erk2, p38). Finally, we describe how this interaction of the KIM is sufficient for overcoming the otherwise weak interaction at the active site of KIM-PTPs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053285      PMCID: PMC2908255          DOI: 10.1021/bi801724n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  46 in total

1.  SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model.

Authors:  A A Vaguine; J Richelle; S J Wodak
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-01-01

Review 2.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

3.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.

Authors:  Juan José Muñoz; Céline Tárrega; Carmen Blanco-Aparicio; Rafael Pulido
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

4.  The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.

Authors:  S M Pettiford; R Herbst
Journal:  Oncogene       Date:  2000-02-17       Impact factor: 9.867

5.  Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases.

Authors:  P J Kennelly; E G Krebs
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

6.  Inhibition of T cell signaling by mitogen-activated protein kinase-targeted hematopoietic tyrosine phosphatase (HePTP).

Authors:  M Saxena; S Williams; J Brockdorff; J Gilman; T Mustelin
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

7.  Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation.

Authors:  M Gronda; S Arab; B Iafrate; H Suzuki; B W Zanke
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

8.  Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition.

Authors:  M Sarmiento; Y A Puius; S W Vetter; Y F Keng; L Wu; Y Zhao; D S Lawrence; S C Almo; Z Y Zhang
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

9.  Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.

Authors:  Tomas Mustelin; Lutz Tautz; Rebecca Page
Journal:  J Mol Biol       Date:  2005-10-03       Impact factor: 5.469

Review 10.  Protein-tyrosine phosphatases and cancer.

Authors:  Arne Ostman; Carina Hellberg; Frank D Böhmer
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

View more
  18 in total

1.  Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activation.

Authors:  Eduard Sergienko; Jian Xu; Wallace H Liu; Russell Dahl; David A Critton; Ying Su; Brock T Brown; Xochella Chan; Li Yang; Ekaterina V Bobkova; Stefan Vasile; Hongbin Yuan; Justin Rascon; Sharon Colayco; Shyama Sidique; Nicholas D P Cosford; Thomas D Y Chung; Tomas Mustelin; Rebecca Page; Paul J Lombroso; Lutz Tautz
Journal:  ACS Chem Biol       Date:  2011-11-17       Impact factor: 5.100

2.  Visualizing active-site dynamics in single crystals of HePTP: opening of the WPD loop involves coordinated movement of the E loop.

Authors:  David A Critton; Lutz Tautz; Rebecca Page
Journal:  J Mol Biol       Date:  2010-11-19       Impact factor: 5.469

Review 3.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

Review 4.  Cellular biochemistry methods for investigating protein tyrosine phosphatases.

Authors:  Stephanie M Stanford; Vanessa Ahmed; Amy M Barrios; Nunzio Bottini
Journal:  Antioxid Redox Signal       Date:  2014-02-25       Impact factor: 8.401

5.  Molecular mechanism of ERK dephosphorylation by striatal-enriched protein tyrosine phosphatase.

Authors:  Rong Li; Di-Dong Xie; Jun-Hong Dong; Hui Li; Kang-Shuai Li; Jing Su; Lai-Zhong Chen; Yun-Fei Xu; Hong-Mei Wang; Zheng Gong; Guo-Ying Cui; Xiao Yu; Kai Wang; Wei Yao; Tao Xin; Min-Yong Li; Kun-Hong Xiao; Xiao-Fei An; Yuqing Huo; Zhi-Gang Xu; Jin-Peng Sun; Qi Pang
Journal:  J Neurochem       Date:  2013-10-31       Impact factor: 5.372

6.  Resting and active states of the ERK2:HePTP complex.

Authors:  Dana M Francis; Bartosz Różycki; Antoni Tortajada; Gerhard Hummer; Wolfgang Peti; Rebecca Page
Journal:  J Am Chem Soc       Date:  2011-10-10       Impact factor: 15.419

7.  Diverse levels of sequence selectivity and catalytic efficiency of protein-tyrosine phosphatases.

Authors:  Nicholas G Selner; Rinrada Luechapanichkul; Xianwen Chen; Benjamin G Neel; Zhong-Yin Zhang; Stefan Knapp; Charles E Bell; Dehua Pei
Journal:  Biochemistry       Date:  2014-01-07       Impact factor: 3.162

8.  Structural basis of p38α regulation by hematopoietic tyrosine phosphatase.

Authors:  Dana M Francis; Bartosz Różycki; Dorothy Koveal; Gerhard Hummer; Rebecca Page; Wolfgang Peti
Journal:  Nat Chem Biol       Date:  2011-11-06       Impact factor: 15.040

9.  Endogenous, regulatory cysteine sulfenylation of ERK kinases in response to proliferative signals.

Authors:  Jeremiah D Keyes; Derek Parsonage; Rama D Yammani; LeAnn C Rogers; Chelsea Kesty; Cristina M Furdui; Kimberly J Nelson; Leslie B Poole
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

10.  Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids.

Authors:  Ekaterina V Bobkova; Wallace H Liu; Sharon Colayco; Justin Rascon; Stefan Vasile; Carlton Gasior; David A Critton; Xochella Chan; Russell Dahl; Ying Su; Eduard Sergienko; Thomas D Y Chung; Tomas Mustelin; Rebecca Page; Lutz Tautz
Journal:  ACS Med Chem Lett       Date:  2011-02       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.